These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stages of development of immunologic response in the regional lymph nodes in invasive cancer of the uterine cervix. Kozlowski H, Hrabowska M. Arch Geschwulstforsch; 1977 Oct; 47(6):550-60. PubMed ID: 607906 [Abstract] [Full Text] [Related]
14. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix. Dini MM, Jafari K, Faiferman I. Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460 [Abstract] [Full Text] [Related]
16. Prospective malignancy grading of invasive squamous carcinoma of the uterine cervix. Prognostic significance in a long-term follow-up. Lindahl B, Ranstam J, Willén R. Anticancer Res; 2007 Jun; 27(4C):2829-32. PubMed ID: 17695455 [Abstract] [Full Text] [Related]
17. [Study of monocyte function in patients with cervical cancer by using T-lymphocyte monocyte interaction in response to phytohemagglutinin (author's transl)]. Umesaki N, Nakade J, Nakamori H, Sako H, Lee T, Sugawa T. Acta Obstet Gynaecol Jpn; 1981 May; 33(5):664-70. PubMed ID: 6972146 [Abstract] [Full Text] [Related]
18. [Immunological status of cervical cancer patients]. Il'in IV, Dekster LI, Letskiĭ VB. Med Radiol (Mosk); 1979 Aug; 24(8):18-22. PubMed ID: 314558 [No Abstract] [Full Text] [Related]
19. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri. Wells SA, Melewicz FC, Christiansen C, Ketcham AS. Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902 [No Abstract] [Full Text] [Related]